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Chitosan (CS) based microparticles for controlled release of theophylline (THP) were obtained by ionic
gelation. The microparticles were characterized by laser diﬀraction analysis (particle size), scanning electron
microscopy (SEM), FTIR spectroscopy, and thermogravimetric analysis. The average diameter of the CSTHP microparticles was 182 μ m. The FTIR spectra conﬁrmed that new hydrogen bonds had formed
between the carbonylic group belonging to THP and the amino group of CS, while the thermogravimetric
analysis showed a modiﬁed stability in the obtained particles and conﬁrmed the presence of an interaction
between the drug and CS. The THP release process was monitored for up to 24 h in simulated gastric ﬂuid
(pH 1.5) and in simulated intestinal ﬂuid (pH 7.4). The release process of THP from microparticles was not
inﬂuenced by the pH of dissolution media. In the ﬁrst 30 min the drug was released in a rapid manner, and
after this stage by a non-Fickian proﬁle.
Key Words: Chitosan, theophylline, microparticles, controlled drug release.

Introduction
Chitosan (CS) (1,4)-[2amino-2-deoxy- β -D-glucan] (Figure 1a) is a polyaminosaccharide obtained from naturally
occurring chitin by partial deacetylation. CS has amine groups that confer a polycationic character and allows
the possibility of forming complex compounds with acids and polycarboxylic acids. CS is a biocompatible
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and biodegradable polymer that has antimicrobial activity, wound healing properties, and numerous medical
applications, especially in the preparation of microparticles and microspheres with entrapped drugs for controlled
delivery. 1−4

Figure 1. Chemical structures of (a) CS; (b) THP.

In acidic medium (pH values lower than 6.5), CS presents a polycationic character and it is soluble due
to the transformation of neutral -NH 2 groups into positively charged –NH +
3 groups. The amino groups can
easily be used for attaching biologically active ligands.
Theophyline (THP) (1,3-dimethylxanthine), an alkaloid found in the leaves of Cameliai sinesis, is used
clinically as a bronchodilator in the management of chronic obstructive pulmonary diseases. 5 The chemical
structure of THP is depicted in Figure 1b.
THP has a short half-life (6 h), and so conventional dosage forms must be administered 3-4 times a day
in order to avoid large ﬂuctuations in plasma concentration. The therapeutic eﬀects of THP appear for plasma
concentration between 5 and 10 μg/mL, and toxic eﬀects occur frequently for concentrations above 20 μg/mL. 6
Due to its numerous side-eﬀects, this drug is now rarely administered as it is. Sustained release dosage forms for
THP provide desirable serum concentrations for prolonged periods without frequent dosing, thereby preventing
patient complications. 7 THP is soluble in acidic and alkaline medium as well. 8

Experimental
CS sample provided by Kemestry Inc. (Sherbrooke, Canada) with M w = 213,800 g mol −1 , deacetylation degree
= 79.7%) and was used without further puriﬁcation. Theophylline was provided by Sigma-Aldrich. All other
chemicals and solvents were of analytical reagent grade. De-ionized double-distilled water was used throughout
the study.
In 100 mL 1% acetic acid solution were solved 0.2 g THP and 1.0 g CS under magnetic stirring. A
phosphate buﬀer solution (pH 8.0) was added dropwise with a peristaltic pump (ﬂow rate = 3 mL/min) to
obtain a ﬁnal pH value of 7.0, to ensure a complete precipitation of the CS-THP complex. After centrifugation
at 4500 rpm for 20 min, the precipitate was separated and freeze-dried (Alpha 1-4 LSC, Christ, Germany).
Size distribution and mean diameter measurements of CS-THP microparticles were recorded using a
SALD-7001 type Laser Diﬀraction Particle Size Analyzer (Shimadzu, Japan). This system is an optic measurement device and uses laser radiation. In the laser diﬀraction particle size analyzer, the particle size distribution
is calculated based on the light intensity distribution data of the diﬀracted light detected by sensor elements.
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The device has a stirring kit to maintain the particles in suspension during the measurements. The obtained
CS-THP particles were measured immediately after synthesis.
A scanning electron microscope (Vega II LSH – Tescan Company) was used to observe the CS-THP
particles morphology.
FTIR spectra were recorded using a FT-IR BOMEM MB 104 spectrometer. The experiments were done
using a resolution of 2 cm −1 and were averaged over 120 scans, in the range of 4000-500 cm −1 . The samples
were mixed with potassium bromide (Merck IR spectroscopy grade), dried and compressed under vacuum.
Thermogravimetric analysis was performed using a Mettler Toledo TGA-SDTA851e system, in nitrogen
atmosphere, with a ﬂow of 20 mL/min, at a heating rate of 10 ◦ C/min using 4-6 mg sample weight. Operating
parameters were kept constant for all the samples in order to obtain comparable data.
Loading eﬃciency was studied by dissolving microparticles (0.05 g) in 100 mL HCl 0.1 N and maintained
for 24 h at 37 ◦ C. The amount of loaded THP was determined by UV spectroscopy (NanoDrop, ND-1000,
Wilmington, DE, USA) at 270 nm wavelength. The concentration of THP in solution was determined using a
calibration curve obtained with known THP samples with concentration in the range of 0.125 to 2μg/mL at
pH 1.5 and pH 7.4. All experiments were carried out in triplicate.
Three measurements were averaged for each data point and the equation of the calibration curve was
obtained by the least-square method. The obtained equation (1) holds for both pH values:
A = 0.0051 × c

(1)

where A is the absorbance and c is the THP concentration in solution, expressed in μg/mL.
THP loading eﬃciency was 60.2% and was calculated by equation (2).
Loading eﬃciency (%) = ma /mt × 100

(2)

where m a is the actual THP content and m t is theoretical THP content.
The in vitro THP release proﬁles were determined as follows: 0.1 g of dried CS-THP microparticles was
suspended in 50 mL of release medium and incubated at 37 ◦ C under shaking (150 rpm) using a GFL WaterBath Shaker. The release media were pH 1.5 (0.1 N HCl solution) and pH 7.4 (phosphate buﬀer solution)
simulating the gastrointestinal tract media. Samples (1 μL) were periodically drawn out from the release media
with microsyringes and the amount of released THP was determined by directly measuring the absorbance by
spectrophotometric method. The in vitro release studies were performed in triplicate for each of the samples.
The percentage of released drug was determined using Equation (3) 9 :
Drug released (%) =

Rt
× 100%
L

(3)

where L and R t represent the initial amount of THP loaded and the cumulative amount of THP released at
time t.

Results and discussion
The result of the laser diﬀraction measurement for the average diameter of the dispersed particles is shown in
Figure 2. As can be seen from this ﬁgure, the average of randomly dispersed particles diameter was around 182
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μm with a Gaussian distribution and standard deviation (S.D.) = 0.150.
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Figure 2. Numeric size distribution for CS-THP microparticles.

SEM images of CS-THP freeze-dried microparticles are shown in Figure 3. These images show that THP
microcrystals were distributed both on the microparticles’ surfaces and also included in their ﬁbrillar structures.

(a)

(b)

Figure 3. SEM micrographs for CS-THP microparticles on magniﬁcation × 2000 of surfaces (a) and cross-section (b).

Figure 4 depicts the FTIR spectra of CS, THP, and CS-THP microparticles. The spectrum of CS powder
had 2 peaks around 897 and 1156 cm −1 corresponding to saccharine structure 10 ; absorption bands at 1654
cm −1 and 1599 cm −1 were detected and attributed to amide I (C=O) and amide II (N-H), respectively, 11 and
the band at 1381 cm −1 was attributed to the distorting vibration of C-CH 3 . 12 At 1321 cm −1 was recorded
the C-N stretch and ﬁnally at 1078 cm −1 appears the peak of the C-O stretch group. In the case of THP, the
broad band at 3456 cm −1 was attributed to N-H stretching vibrations. Bands at 3059, 2986, 2918, and 2824
cm −1 were due to both aromatic and aliphatic C-H stretching vibrations. The band at 1717 cm −1 represented
the imide group stretching of the heterocyclic ring. The sharp band at 1668 cm −1 was due to tertiary amide
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group stretching vibration. N-H bending vibration was represented by a band at 1566 cm −1 . The band at 1242
cm −1 shows C-N stretching vibrations. 13 In the complex THP-CS the bands characteristic for CS and THP
are found. The band at 1599 cm −1 was not seen in the spectrum of THP-CS microparticles. From this result,
it was concluded that a hydrogen bond had formed between the carbonylic group of THP and the amino group
of CS.
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Figure 4. FTIR spectra of raw CS, THP, and CS-THP microparticles.

Thermal properties are interesting in view of the structure-property relationship and for practical
applications. 14,15 . Thermogravimetric (TG) curves and diﬀerential thermogravimetric (DTG) curves, recorded
in conditions described above for the precursors and CS-THP microparticles, are shown in Figures 5 and 6. The
TG characteristics are presented in the Table, where T onset is temperature at which the degradation begins in
each step, T endset - the temperature at which degradation is ﬁnished in each given step, T peak - the temperature at which the degradation rate is maximum, W% - the percentage mass loss, and Residue - represents
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the ash that is left after heating the sample to 900 ◦ C.
Table. Thermogravimetric characteristics for CS, THP, and CS-THP microparticles.

Sample

Step

Tonset (◦ C)

Tpeak (◦ C)

Tendset (◦ C)

W (%)

Residue

I

51

78

108

7.50

II

275

300

502

65.19

THP

I
II
III

269
366
491

349
450
668

366
491
711

73.63
14.33
2.26

9.78

CS-THP

I
II

54
242

79
269

114
425

7.66
50.02

42.32

CS

27.31

Examining these curves and data from the Table, we can conclude that the thermal degradation runs in
2 or 3 stages. The ﬁrst step corresponds to dehydration processes and mass loss in this stage yields information
about the sample water content. The degradation peak for CS-THP complex is unique and was shifted compared
to THP and CS degradation peaks, proving that a solid dispersion was obtained.
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Figure 5. Thermogravimetric curves (TG) for the pre-

Figure 6. Diﬀerential thermogravimetric curves (DTG)

cursors and CS-THP.

for the precursors and CS-THP.

Generally speaking, drug release from CS-based particulate systems depends upon the extent of crosslinking, morphology, size and density of the particulate system, physicochemical properties of the drug, and the
pH of the dissolution media. 16
The in vitro release proﬁles of THP from particles at pH 1.5 (HCl solution) and at pH 7.4 (phosphate
buﬀer) are depicted in Figure 7. We observe that THP was released to completion within 8 h, with release
behaviors similar under both pH conditions.
During the ﬁrst 30 min, about 65%-70% of the loaded THP was released from the microparticles. This
behavior may be attributed to the rapid dissolution of THP adsorbed on the microparticles’ surface.
Similar THP release proﬁles were obtained in the case of CS-THP solid dispersions obtained by spraydrying method and in the case of glutaraldehyde cross-linked protein based microcapsules loaded with THP. In
the ﬁrst case almost 70% of the loaded drug was released in the ﬁrst 30 min. At pH 1.2, the dissolution proﬁles
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of the drug from physical mixture and solid dispersions were almost the same. In the alkaline medium (pH
6.8), the release rate of the spray-dried pharmaceutical was sustained more than the original and the physical
mixture. In the second case, the complete core release from the protein based microcapsules was observed after
20 min in simulated gastric ﬂuid and after 30-50 min in simulated intestinal ﬂuid, at 37 ◦ C. 17,18
After the 30 min rapid dissolution, the drug continued to be released from the obtained CS-THP
microparticles until completed between 0.5 and 8 h. For a brief evaluation of the drug release proﬁle in this
time interval a semi-empiric mathematical model was applied, developed by Korsmeyer and Peppas, with the
following equation 19 :
Mt /M∞ = ktn

(4)

where M t / M ∞ represents the released drug fraction plot of time t, k – kinetic constant cumulating both
polymer and drug properties, and n – the exponent used to characterize the transport mechanism. For n =
0.4 the drug is released by Fickian diﬀusion, for 0.45 < n < 0.89 the non-Fickian case is applied (anomalous
diﬀusion), and for n = 0.89 – a zero order release proﬁle. 20,21
As shown in Figure 8, it was found that between 0.5 and 8 h (n = 0.8254 for pH 1.5 and n = 0.7788 for
pH 7.4) the drug was released from CS-THP microparticles by a non-Fickian mechanism.
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Figure 7. THP in vitro release proﬁles from CS-THP

Figure 8. Ln(M t / M f ) versus ln(t) plot for CS-THP

microparticles. Each result show the mean ± SD (n = 3).

microparticles.

Drug release was not aﬀected by the medium pH, because the release process was controlled by the drug
diﬀusion. This in vitro release behavior suggests that the interaction between THP and positively charged CS
polymer is weak, allowing the THP to be released from microparticles by a dissociation mechanism.

Conclusions
Chitosan based microparticles for the controlled theophylline (THP) release were obtained by ionic gelation.
THP release proﬁles at pH=1.5 and pH=7.4 do not exhibit obvious diﬀerences, due to the presence of weak
interactions, namely hydrogen bonds between the carbonylic group of THP and the amino group of CS. The
maximum amount of released THP was achieved after 8 h in both pH conditions.
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